San Diego-based Auxilium Biotechnologies designed the investigational NeuroSpan Bridge device to accelerate nerve regeneration and nerve targeting after debilitating nerve injuries to extremities. About 3% of civilian trauma cases and 30% of military trauma cases involve nerve injury, said Auxilium Biotechnologies CEO Jacob Koffler.

“Nerves don’t regenerate where they need to go. They do that very randomly, sometimes even going backward towards the proximal end,” Auxilium Biotechnologies CEO Jacob Koffler said in an interview. “What we have is a technology that is able to organize this regeneration, keep them in the same pathway and bring them to the original target that was denervated due to the injury.”